Neurogenic Tumours of the Mediastinum
Schwannoma, neurofibroma, ganglioneuroma, pheochromocytoma, and the dumbbell tumour problem.
Overview
Neurogenic tumours are the most common mediastinal tumours overall (20%), arising predominantly in the posterior mediastinum (paravertebral compartment). They arise from peripheral nerves, nerve sheaths, or the sympathetic chain. In adults, the majority are benign; in children, malignant neurogenic tumours (neuroblastoma, ganglioneuroblastoma) are more common and carry a worse prognosis.
| Cell of origin | Benign | Malignant |
|---|---|---|
| Nerve sheath tumours | ||
| Schwann cells | Schwannoma (neurilemmoma) | Malignant peripheral nerve sheath tumour (MPNST) |
| Schwann cells + fibroblasts | Neurofibroma | Malignant neurofibroma (von Recklinghausen) |
| Autonomic ganglia tumours | ||
| Sympathetic ganglia | Ganglioneuroma | Ganglioneuroblastoma · Neuroblastoma |
| Paraganglioma | ||
| Chromaffin cells | Paraganglioma (non-functional) | Pheochromocytoma (functional) |
Nerve sheath tumours
Schwannoma (neurilemmoma)
The most common benign neurogenic tumour. Well-encapsulated, soft, yellowish tumours attached to peripheral nerves — stain with S-100 protein. Two histological patterns: Antoni A (organised palisading pattern — Verocay bodies) and Antoni B (loose reticular pattern). Complete excision within the capsule is curative. Association with neurofibromatosis type 2 (NF2). May be associated with von Recklinghausen disease (NF1).
Neurofibroma
Benign nerve sheath tumour arising from non-myelinating Schwann cells, fibroblasts, and axons. Commonly associated with neurofibromatosis type 1 (NF1 / von Recklinghausen disease). Pseudo-encapsulated and appear to be part of the nerve of origin rather than attached to it — unlike schwannoma, cannot be separated from the nerve. Plexiform neurofibromas in NF1 carry a 10–15% lifetime risk of malignant transformation to MPNST.
Malignant peripheral nerve sheath tumour (MPNST)
Malignant schwannomas occur predominantly in von Recklinghausen disease. Locally aggressive with high local recurrence. Radical surgical excision with clear margins is the cornerstone of treatment — chemotherapy and radiotherapy have limited efficacy. Prognosis is poor for unresectable or metastatic disease.
Autonomic ganglia tumours
Ganglioneuroma
Well-differentiated, benign tumour arising from neural crest cells of the sympathetic ganglia. Typically found in children and young adults. Paravertebral location — may extend into multiple intercostal foramina. Complete resection is curative. Can produce VIP (vasoactive intestinal peptide) causing watery diarrhoea syndrome.
Neuroblastoma and ganglioneuroblastoma
Malignant tumours arising from primitive sympathetic neuroblasts. Most common in children under 5 years. May secrete catecholamines and VIP. Staging by International Neuroblastoma Staging System (INSS). Treatment: multimodal — surgery, chemotherapy, radiation, bone marrow transplantation in advanced disease.
Pheochromocytoma / paraganglioma
2% of extra-adrenal pheochromocytomas occur in the chest. Associated with multiple endocrine neoplasia (MEN 2A, 2B), von Hippel-Lindau syndrome, and Carney triad (pulmonary chondromas + gastric GIST + extra-adrenal paraganglioma). Mediastinal pheochromocytomas have a higher propensity for malignancy than adrenal counterparts. Functional tumours produce catecholamines causing paroxysmal hypertension, headache, sweating, and palpitations.
Alpha-blockade (phenoxybenzamine) for a minimum of 10–14 days before surgery — prevents hypertensive crisis during tumour manipulation. Add beta-blockade only AFTER adequate alpha-blockade. Ensure adequate fluid loading. Intra-operative arterial line and experienced anaesthesia mandatory. Have phentolamine and nitroprusside available for hypertensive surges.
Dumbbell tumours
Some posterior mediastinal neurogenic tumours extend through the intervertebral foramen into the spinal canal — giving a "dumbbell" or "hourglass" shape on MRI. This is critical to identify pre-operatively because inadequate decompression of the intraspinal component risks spinal cord injury from haematoma or swelling.
MRI is mandatory before any posterior mediastinal neurogenic tumour resection to rule out intraspinal extension. When dumbbell extension is confirmed, combined neurosurgical and thoracic surgical management is required — typically staged or simultaneous decompressive laminectomy followed by thoracoscopic or open resection of the mediastinal component.
Investigations
- MRI: investigation of choice — better than CT for delineating intraspinal extension, neural foraminal involvement, and cord compression
- CT chest: characterises the mass, rib erosion, calcification
- 24-hour urinary catecholamines and metanephrines: mandatory for posterior mediastinal tumours to exclude functional pheochromocytoma
- MIBG scan: for paraganglioma and neuroblastoma — identifies multifocal disease and metastases
Treatment
Surgical excision in toto without breaching the capsule is curative for benign neurogenic tumours. Approach by thoracotomy, VATS, or robotic surgery. Recurrence is rare for benign tumours. For malignant tumours, local recurrence is common and overall prognosis is poor despite multimodal therapy.
All clinical content should be verified against current guidelines before clinical application. This resource is intended for revision and educational purposes only.
Standard textbooks
- Shields TW, LoCicero J, Reed CE, Feins RH. General Thoracic Surgery. 7th ed. Lippincott Williams & Wilkins.
- Sellke FW, del Nido PJ, Swanson SJ. Sabiston & Spencer Surgery of the Chest. 9th ed. Elsevier.
- Pearson FG, et al. Thoracic Surgery. 3rd ed. Churchill Livingstone.